Diversity in COVID-19 Science | Community Engagement Alliance

Safety always guides the scientific pathway toward vaccines and treatments. Safety steers scientific leaders who review and fund research, informs recruitment of volunteers who partner with researchers and participate in clinical trials, frames the rigorous and continuous oversight of studies, determines regulatory approval, guides engagement efforts in communities, and directs doctors and nurses who bring discoveries to patients.

At each step on the pathway, we can find people like us – a diverse group of people. Here are just a few who are working every day to help us conquer the pandemic.

Meet People at Each Step on the Pathway

Fund | Research | Ensure Safety | Volunteer | Provide Care

Fund

Public Health Funders, like NIH, conduct extensive reviews – including peer review – of proposed studies before funding research. Peer review is an independent evaluation by others working in the same field.

Dr. Gary H. Gibbons

Director, National Heart, Lung, and Blood Institute

"Science is part of the solution to ending this pandemic. It's important that communities of color participate in that research to define what's safe and effective, but also the research that will ultimately end this pandemic. We want our most adversely affected communities to get the most benefit from the science."

Hear what Dr. Gibbons says on why we should all get a COVID-19 vaccine.

Dr. Eliseo J. Pérez-Stable

Director, National Institute on Minority Health and Health Disparities

"As we navigate through this pandemic, leaders in and members of communities of color have a significant role to play to promote trust in science. From leading scientific research to being participants in the research, we need to highlight the contribution of minorities and their commitment to work together for a better future for everyone."

Ready to take another step?

Research

Researchers in labs and clinics work with their teams on studies that answer important scientific questions about health conditions, treatments, and vaccines. Other researchers working in communities, including the research supported by CEAL, focus on the needs of local communities at the neighborhood, city and state level. This community-engaged research connects with local leaders and organizations to forge lasting partnerships with the goal of finding the best ways to advance the well-being of people where they live.

Research in Labs and Clinics

Dr. Maria Elena Bottazzi

Co-Director, Texas Children’s Hospital Center for Vaccine Development, Texas Children’s Hospital

"As a microbiologist and pediatric infectious disease researcher, I have worked on developing safe and effective vaccines against SARS and MERS and now COVID-19. We are using our decade long coronavirus vaccine research experience to inform our current work to save lives globally. We must continue to build trust in science and trust in research so that people, regardless of whether they live in India, Honduras or the U.S., understand that vaccines are safe, effective and essential to prevent or reduce COVID-19."

Dr. Katya Corado

Dr. Kizzmekia S. Corbett

Assistant Professor of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health

"As a scientific researcher who was on the front lines during the development of these vaccines, I strongly believe in them. And as an African American, I absolutely understand the mistrust and the hesitancy to take the vaccine. But the vaccines are a way for us to really start to equalize the playing field when we're thinking about health disparities."

Dr. Jaime Fergie

Pediatric Infectious Disease Specialist, Director Infectious Diseases, Driscoll Children's Hospital

"As a pediatric infectious disease expert and father who has given his children the COVID-19 vaccine, I want to tell families that the vaccines are safe, highly effective, and have been studied extensively. I encourage you to protect your family and your children, so you will be able to go back to your normal life."

Dr. Genevieve Fouda

Adrianne Gladden-Young

Senior Research Associate, Infectious Disease and Microbiome Program, Sabeti Lab, Broad Institute of MIT and Harvard

"Since the beginning of the pandemic, I’ve worked in the lab to research the virus that causes COVID-19. I started following the scientific research happening around the US, and noticed that some populations which were disproportionately hit by COVID-19, specifically the black, brown, and indigenous populations, were left out of this research that could benefit them. As a black scientist, I felt compelled to call attention to this because it is important for science to include – not target – people of color in the research that can keep them safe, and save their lives. I’m encouraged by the efforts being made to diversify research participation at every step along the scientific pathway."

Dr. Bin Guan

Fellow, Ophthalmic Genomics Laboratory, National Eye Institute

"As a researcher, I have been working in a lab during the pandemic to develop a sensitive COVID-19 test that can better determine the different viral loads from patient to patient. This will help improve response time and treatments during the pandemic. The new test is sensitive, fast, economical, and also offers enhanced safety for laboratory personnel. I often tell my family and friends that COVID-19 is an insidious disease with a wide range of symptoms. When the virus replicates, new mutations occur; thus, we are in a race with the virus. Get vaccinated so that the virus has less chance to mutate."

Dr. Ibukun Kalu

Assistant Professor, Division of Pediatric Infectious Diseases, Medical Director, Pediatric Infection Prevention, Duke University Medical Center

"I work to ensure that we reduce the chances our children get infected with COVID-19. As this pandemic evolves, we need to continue meeting communities where they're at and keep providing resources, because some communities will be unduly impacted by COVID-19 even as other communities are moving past COVID-19."

Dr. Njira Lucia Lugogo

Pulmonologist, Clinical Associate Professor of Internal Medicine, Asthma Program Director, Division of Pulmonary & Critical Care Medicine, University of Michigan

"I'm a pulmonologist, and when the pandemic began, I was very concerned for my patients with lung disease, and I also felt a bit helpless. I realized the best way to overcome this emotion was to become engaged in finding solutions and I became a part of COVID vaccine trials as a principal investigator. We followed all the safety protocols put in place by our university review board and the FDA. Now that the vaccine is approved, I can look all of my patients in the eye and assure them that the vaccine not only works but is safe."

Dr. Amaran Moodley

Associate Clinical Professor in the Division of Infection Diseases, Department of Pediatrics - University of CA, San Diego Rady Children's Hospital

"As a father of two young children and as a pediatric infectious disease researcher directly involved in COVID-19 vaccine trials, I too weighed the risks and benefits of vaccinating my own children. Based on the safety and efficacy demonstrated in the pediatric clinical trials, I felt comfortable vaccinating my children, and I understood the impact that vaccinating all children could have on slowing the spread of COVID-19 in our communities."

Dr. Ian Moore

Veterinary Pathologist, Chief, Infectious Disease Pathogenesis Section, National Institute of Allergy and Infectious Diseases

"As a veterinary pathologist and infectious disease researcher at NIH, I reviewed some of the first samples derived from COVID-19 animal model studies for these vaccines. It was my job to determine how safe and effective these vaccines are, in the pre-clinical setting, before they are introduced to human clinical trial participants. It is my passion to communicate the safety and efficacy of these vaccines, and how they work, to people in the community."

Dr. Sheena Mukkada

Infectious Disease Clinician, St. Jude Children's Research Hospital

"We know that viruses evolve over time, and we've seen the sequential waves of COVID-19 infection, the same way we see with flu every year, which is why we have to get an annual flu vaccine. So, it makes sense that we might need to get another vaccine for COVID following the same model that we have for flu. Just as we would accept getting a seasonal flu vaccine, we will likely have to accept getting a seasonal COVID vaccine to make us ready to face the new challenge of the specific COVID variant that is circulating."

Dr. Pauline K. Park

Professor of Surgery, Co-PI, Michigan Center, NHLBI Prevention and Early Treatment of Acute Lung Injury clinical trials network

“At the beginning of the pandemic, our NHLBI clinical trials network — called the Prevention and Early Treatment of Acute Lung Injury clinical trials network, or PETAL for short — pivoted to COVID; it was so important to bring strong science to inform patient care. PETAL has participated in clinical trials of monoclonal antibodies and therapeutics, anticoagulation and host tissue response, and immunomodulation. As a clinician providing ECMO support for severe respiratory failure, I saw the impact that COVID has had on patients throughout our community. I am grateful to help bring science and evidence-based treatments to offer the best care we can to everyone.”

Dr. Marcos Ramos-Benitez

Postdoctoral Research Associate Fellow, National Institute of General Medical Sciences

"In clinical trials, representation is highly relevant because in order to say that something works, you need diverse groups and cohorts that are actually representative of the people who will need access to the medication that you're researching. Not only is representation important in clinical trials, so is community engagement when researchers are trying to build confidence and trust in different populations."

Dr. Kanecia Obie Zimmerman

Associate Professor of Pediatrics, Duke University

"The COVID-19 vaccine has been proven to be safe and effective in children through extensive study. Deciding to ‘just get infected with COVID-19 and get it over with’ is like rolling the dice; vaccination is the only way to really know that your child’s chance of having severe COVID-19 disease is extremely low."

Ready to take another step?

Research in Communities

Shawnell Damon

Dr. Mona AuYoung

Associate Director of Community Engagement, Clinical and Translational Science Award, Scripps Health and Scripps Research Translational Institute

"Community-engaged researchers help to bridge the gap between scientists and communities by actively listening to community members and co-designing studies that advance science and are also relevant to communities. We work closely with community leaders, community members, and researchers to discuss everything from how to set up community vaccination events with wraparound services or how to create brief informational resources to answer questions about COVID-19 in a clear and accurate way. Even after COVID-19, we want to help to bring these worlds closer together so that scientific priorities can better align with community priorities."

You can read more about Dr. AuYoung's work in the Engagement Spotlight, A Leap of Faith.

Rev. Dr. Kendrick E. Curry

Senior Pastor, Pennsylvania Avenue Baptist Church

"I’m a pastor and former scientific researcher in engineering and I serve on the scientific advisory committee for DC Health. We started a vaccination pilot study in February, working with city partners, health centers, and vaccine administrators to develop a model that would rotate vaccinations at houses of worship in the city. We identified credible, trusted messengers to explain to their community how the vaccine is safe, efficacious, and saves lives. Churches who serve the most vulnerable Black and Brown communities are able to spread the good word of vaccination to the church and community members. Prayerfully, we can achieve the goal of herd immunity in the communities that we serve. I tell my congregation that I'm following the science closely; that I trust and believe in it. That's why I got vaccinated and why it's so important for everyone else to do the same. Vaccinations save lives, so get vaccinated today!”

Venus Ginés

Dr. Raynald Samoa

Clinical Lead for the National Pacific Islander COVID-19 Response Team in the United States, Endocrinologist, City of Hope

"I am a physician researcher and have been monitoring the impact of COVID-19 on Native Hawaiian and Pacific Islander (NHPI) communities. I helped conduct a study to see how NHPI communities have been affected by the pandemic and I understand that a large percentage NHPIs are still hesitant to receive the COVID-19 vaccine. I speak to the cultural responsibility of our communities to keep each other safe and advocate to end the disproportionately devastating effects of the pandemic on NHPIs."

Dr. Victor Sutton

Director, Preventive Health & Health Equity Principal Investigator, Community Engagement Center, Jackson Heart Study COVID-19, Health Disparity State Team Lead, Mississippi State Department of Health

"As a community-engaged researcher, I play a vital role in making sure my community is represented in all health fronts, and COVID is no different. Bringing awareness and education into the community is vitally important to me, and building a relationship with community members allows me to reach their hearts and minds when we discuss the importance of getting vaccinated."

Ready to take another step?

Ensure Safety

Safety Monitors serve on Institutional Review Boards (IRBs) or Data and Safety Monitoring Boards (DSMBs). An IRB oversees the design and implementation of a study and approves information that is shared with research participants. A DSMB is a body of experts who are independent of the research study that regularly check a clinical trial’s data to continually assess the safety and performance to protect volunteer participants.

Dr. Evi Abada

Regulatory Specialist, Pediatric Studies, Resident Physician, Anatomic and Clinical Pathology

"SARS and MERS were both coronaviruses. Researchers understood the family of viruses and they were able to use that information quickly to adapt and address the SARS CoV-2 virus. Even when a clinical trial is completed, there is often follow-up with the study participants for up to two years and beyond (depending on the study design) after the study’s conclusion to ensure there are no other long-term effects for participating patients."

Dr. Andrew Campbell

Director, Comprehensive Sickle Cell Program, Children’s National Health System

“My expertise on the Data Monitoring Safety Board allows me to really provide some comfort for my families to say, ‘Hey, I can tell you I have watched this happen from the beginning to the end, and I feel comfortable that this same process is implemented within the COVID-19 vaccine trials as well.’”

Laurie Carr

Senior Clinical Research Associate, Site Management, Therapeutic Delivery Unit – Central Nervous System & Cardiovascular, Regional R&D Solutions Operations, IQVIA

"As a Clinical Research Monitor, my job is to support study investigators and staff by providing training and guidance for study procedures; ensuring the conduct of the trial adheres to local and federal regulations; and most importantly, that the rights and safety of study participants are the highest priority, guiding any and all study activities over the course of the trial. As a monitor on COVID-19 trials, and as a bi-racial woman of color, I explain to family and friends the importance of these vaccines as well as the safeguards, diligence and dedication that supported their development.”

Dr. Lisa A. Cooper

Bloomberg Distinguished Professor, Johns Hopkins Bloomberg School of Public Health

"As a safety monitor in the COVID-19 clinical trials, it is my responsibility to protect volunteer participants and make sure their safety is the highest priority. My role allows me to ease any concerns raised by family and friends and make sure they continue to trust the science. I can say with the utmost confidence that this vaccine is safe and effective."

Dr. Jaime G. Deville

Clinical Professor of Pediatrics, Division of Infectious Diseases, David Geffen School of Medicine; Director of the Care-4-Families Clinic, University of California, Los Angeles, UCLA Mattel Children's Hospital

"As a pediatrician from Peru, I have seen firsthand the loss and devastation of this pandemic on my community and family. I have been studying vaccines for over 20 years, and as a safety monitor for the COVID-19 vaccines and treatments, I can state with full confidence that safety was taken into account every step of the way. I have received the vaccine and my family is fully ready when it is their turn."

Ysabel Duron

President/Executive Director, The Latino Cancer Institute

"As a member of an Institutional Review Board, participant safety and racial and ethnic inclusion in research projects are of utmost importance to me. Not only is inclusion in research and clinical trials important to the knowledge and health of these communities, it's ethically and morally right. It's not only good science, it's just science!"

Dr. Jennifer Knight-Madden

Professor of Pediatric Pulmonology & Clinical Research; Director, Sickle Cell Unit, The Caribbean Institute for Health Research, The University of the West Indies

"As a member of local and regional Ethics Committees and a Co-Chair of two study independent review boards, I believe that the benefit must always outweigh any risk taken by participants in research studies. In looking after patients, I see research as an effort to find better ways to prevent disease and treat persons with illnesses. Although we don't know everything, I have myself been vaccinated and I am convinced that the benefits of being vaccinated outweigh the risks. I am encouraging health workers, at-risk adults, other front-line workers, and all who can be vaccinated to do so."

Dr. Geeta Krishna Swamy

Dr. Hsin-Chieh "Jessica" Yeh

Sr. Epidemiologist, Osler Housestaff Research Program, Associate Professor of Medicine, Johns Hopkins Medicine

"I’m a researcher who also serves on a Data and Safety Monitoring Board for an ongoing COVID clinical trial that focuses on prevention. Being a safety monitor allows me to ensure that the health, safety, diversity, and best interest of the clinical trial participants are always the top priority for everyone involved. When I talk to my friends and family about COVID-19, I bring a sense of confidence. Knowing that I am one of the many making sure all protocols are being followed and all participants are kept safe allows me to ease concerns they may have and reinforce their trust in science."

Ready to take another step?

Volunteer

Volunteer Participants choose to take part in clinical trials and partner with researchers to share their unique, lived experiences to help advance science. The NIH is committed to supporting clinical trials with diverse participants.

Emelina Asto-Flores

CaRE2 Community Health Educator with CEAL, College of Pharmacy, University of Florida

"As a Latina community health educator, it was very important to me to volunteer as a COVID-19 clinical trial participant. Doing so has allowed me to speak from experience when addressing concerns about the vaccine and its development. My participation is one step closer to ensuring my community knows that people who are like them are represented in clinical research."

Geraldine Bradshaw

Dr. Craig E. Cameron

Jeffrey Houpt Distinguished Investigator, Professor and Chair, Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill

"I volunteered for a vaccine trial because I wanted to make sure that sufficient data could be collected in a timely enough fashion to facilitate approval and distribution. As a Black man, it was also important to me that my demographic was represented to demonstrate safety and efficacy. I received the placebo in the trial, but later received my first dose. Even after only the first dose, I felt a sense of peace like I had not felt in a long time. Being more than two weeks out from my second dose, I no longer have to ponder trivial tasks like my weekly grocery shopping as if they were a death-defying mission. I still wear a mask and actively social distance to protect others, but I now get to socialize with my family and friends who are also vaccinated. The positive impact vaccination has had on my life and living cannot be overstated."

Dr. Keisha L. Gibson

Associate Professor of Medicine and Pediatrics, DOM Vice Chair of Diversity of Inclusion, Chief, Pediatric Nephrology, UNC Kidney Center, University of North Carolina at Chapel Hill

"Having been an investigator in many clinical trials, I often relied on the altruistic willingness of patients to help our community expand knowledge even if it may not benefit them directly. Actions speak louder than words, and this was my turn to do the same for my colleagues, patients, family and friends. Now, knowing that I received the vaccine, I can speak with confidence when asked, 'how will the vaccine make me feel?' or 'how will I feel months from now?'"

Marcia Jackson-Hooper

Retired Pediatric Nurse Practicioner

"After being a pediatric nurse for 50 years, I retired in 2017. When I read that they were looking for people of color to participate in the COVID-19 clinical trials, I jumped at the chance. Since the time I started in the trial, I’ve come out of retirement and am conducting COVID testing at eight different schools. I receive so many questions from family, friends, teachers, and my community about the coronavirus, the effectiveness of the vaccine, and what it’s like to be a part of a clinical trial. Now I can answer them from a point of authority because I’m part of the trial.”

Julia Kachar

Mir Majeed

Dr. Richard Moye

Associate Professor of Sociology, Chair of Department of Behavioral Sciences, Winston-Salem State University

"As an Associate Professor of Sociology, I teach students about research ethics and the protections that are in place for any research having to do with people. I had no apprehension about this process and I know how important the vaccine will be for combating the pandemic. After experiencing nothing more than normal side effects, I encourage everyone to get the vaccine as soon as it becomes available to them."

Justice Zimmerman

Ready to take another step?

Provide Care

Healthcare Providers bring scientific discoveries, like COVID-19 treatments and vaccines, to their patients in everyday practice. Doctors and nurses are among the most trusted sources for health and medical information.

Dr. Hina Talib

Pediatrician, Atria Institute

“I think that having questions about the vaccine makes you human and makes you a parent, and I highly respect anyone who wants to learn more about the vaccine. COVID illness does reach children, and some children do get really sick. What the COVID-19 vaccine does is protect our children from getting seriously ill and from potential death. The vaccine gives their body a blueprint and best chance to fight the infection.”

Dr. Carolyn Allen

Family Nurse Practitioner, National Institute for Nursing Research, Division of Intramural Research

"Being a nurse practitioner at the NIH has allowed me to make an impact on my patients, as well as my community. As a healthcare volunteer at the largest predominantly African American church in the United States, I am sharing information about ways to prevent COVID exposure, advocating for vaccinations, promoting participation in future research, and mentoring youth and adults to become healthcare providers. We are also partnering with the University of MD Capital Region Health to have COVID vaccines administered in our community."

Monica Atkinson

Research Nurse, Nurse Coordinator, Section of Sensory Science and Metabolism, National Institute for Nursing Research, Division of Intramural Research

"I am a Clinical Research Nurse at the NINR, a volunteer Covid-19 participant at NIAID, and was diagnosed as an Asymptomatic Covid-19 positive patient at the NIH. I have completed my vaccination course at NIH and welcome the opportunity to have open conversations with my community of family and friends regarding COVID-19 vaccine development. I best serve my community by offering the tools of real data, sharing my personal experience, and being an advocate for participants."

Dr. Olveen Carrasquillo

Professor of Medicine and Public Health Sciences, Chief, Division of General Internal Medicine, University of Miami

"As a Latino physician, with more than 20 years of experience, it is very important to me that our hardest-hit communities receive the care and education they need and deserve. To ensure my community survives COVID-19, I educate my patients, family, and friends on the science surrounding COVID-19 and vaccine development."

Dr. Alejandra Casillas

Assistant Professor of Medicine in Residence, Division of General Internal Medicine and Health, Services Research, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles

"As a primary care physician at an academic medical center in Los Angeles, where I also care for patients at one of the largest free clinic systems in the nation, the majority of my patients are low income and Spanish speaking. In addition to helping patients navigate the health system for necessary medical care and also for issues related to the COVID-19 pandemic, I see it as my personal mission to share trusted resources and educate my patients on the safety and effectiveness of the vaccines authorized for emergency use by the FDA. I tell my patients that I am the daughter of Spanish-speaking Mexican immigrants, and I personally drove them to get the vaccine, because I believe in, and trust the science."

Dr. Yelba M. Castellon-Lopez

Assistant Professor, Department of Family Medicine, David Geffen School of Medicine, University of California, Los Angeles

"As a researcher and primary care doctor who works closely with the Hispanic/Latino community, I use my background in medicine and science to address misinformation and myths in the communities that have been impacted by the pandemic the most. I have connected with the Hispanic/Latino community through community-based partnerships to inform them about COVID-19 prevention and vaccine efficacy and safety in Spanish. My goal is to empower my patients to make informed choices about getting the vaccine based on science."

Dr. Chyke A. Doubeni

Professor of Family Medicine, Center for Health Equity and Community, Engagement Research, Mayo Clinic Cancer Center, Center for Clinical and Translational Science, Mayo Clinic

"Being active in my community practicing family medicine, it was very important for me to enroll in a COVID-19 clinical trial. My wife helped oversee the home medical care of people with COVID-19. I wanted to be able to speak from firsthand experience when addressing patient concerns about the development of the vaccine and set an example for our teams. I now tell everybody - friends, patients, and communities- with confidence, that getting the vaccine is safe. I know that because I was involved."

Dr. Robert Gillespie

Cardiologist, Sharp HealthCare

"I created videos and enrolled in a clinical trial to speak to my church and community not only as an informed healthcare provider, but also from experience and to share the facts as someone who is taking part in the scientific process. When I administer vaccines in my high-risk communities, I see the reassurance and sense of peace it gives people knowing that they have done their part to keep their family and community safe."

Dr. MeiLan Han

Professor, Internal Medicine, Division of Pulmonary and Critical Care, University of Michigan

"As a physician and researcher with a focus on chronic lung disease and COPD, several of my patients have become sick with COVID-19, and I strongly recommend that everyone gets vaccinated as soon as they can. I drove my mother and 100-year-old grandmother to get their vaccinations, and did so because I knew it was safe. Working directly with patients allows me to provide advice on getting vaccinated, assist in registering those who do not have access, and also fight the misinformation that people come across every day."

Dr. Paule V. Joseph

Lasker Clinical Research Scholar, Tenure-Track Investigator (Clinical), Principal Investigator, NIH Distinguished Scholar, Sensory Science and Metabolism Unit, Biobehavioral Branch, Division of Intramural Research

"My duty as a Nurse Practitioner is to provide evidence-based care, educate the patients by delivering accurate up to date data and explain findings in simple terms. As a Black, female clinical researcher, I'm able to use my knowledge in genomics to provide accurate responses to the people that surround me and dismantle some of the myths that lead to vaccine hesitancy. We need to go where the community is, answer their questions so they make an informed decision. And as the first person in my family to be vaccinated, it's important for me to lead by example and show my family, friends, and patients that the vaccine is safe."

Dr. Yvonne (Bonnie) Maldonado

Professor of Pediatrics and of Epidemiology and Population Health, Chief, Division of Pediatric Infectious Diseases, Stanford University School of Medicine

“We want people to talk to their pediatricians or their health care providers about these vaccines to make sure they feel comfortable with them, and to recognize that they're safe and can prevent infections that can lead to hospitalization and death, because we don't really know how to predict which children will wind up getting very sick.”

Tabe Mase

Director of Employee Health Services, ChristianaCare Health System

"As a nurse practitioner and director of employee health at my organization, we believe and trust in science. Then we explain and discuss the science in the language and ways our patients can fully understand. Doing so ensures that we are anticipating our patients' needs, and what actions they need to keep themselves safe."

Dr. Ilan Shapiro Strygler

Dr. Cydney Teal

Chair, Department of Family & Community Medicine, Service Line Leader, Primary Care & Community Medicine Service Line, ChristianaCare

"As a leader in primary care and community medicine, I come to work each day to provide care alongside an exceptional team of front-line clinicians and caregivers. When I return home and look at my two young children, I know that the care we provide is also helping to keep them, our family, and our neighbors in the communities safe."

Dr. Felix M. Valbuena, Jr.

Dr. Nita Vangeepuram

Associate Professor, Pediatrics, Icahn School of Medicine at Mount Sinai

"As a pediatrician and as a mom, the thing that I was really afraid about is the worst-case scenario. It might be rare, but kids do get hospitalized, and kids have died from COVID-19. When I saw data about how effective the COVID-19 vaccines are against preventing dire consequences for children, I wanted to make sure my kids were protected by giving them the vaccine."

Dr. Zanthia Wiley

Director of Antimicrobial Stewardship, Emory University Hospital Midtown

"As an infectious diseases doctor, I feel comfortable telling my patients that COVID-19 vaccines are safe and effective. They save lives and will decrease the likelihood of you being hospitalized or becoming severely ill. I recommend speaking to your doctor about COVID-19 vaccination. They are trusted sources of accurate information."

Meet People at Each Step on the Pathway

Fund

Dr. Gary H. Gibbons

Dr. Eliseo J. Pérez-Stable

Ready to take another step?

Research

Research in Labs and Clinics

Dr. Maria Elena Bottazzi

Dr. Katya Corado

Dr. Kizzmekia S. Corbett

Dr. Jaime Fergie

Dr. Genevieve Fouda

Adrianne Gladden-Young

Dr. Bin Guan

Dr. Ibukun Kalu

Dr. Njira Lucia Lugogo

Dr. Amaran Moodley

Dr. Ian Moore

Dr. Sheena Mukkada

Dr. Pauline K. Park

Dr. Marcos Ramos-Benitez

Dr. Kanecia Obie Zimmerman

Ready to take another step?

Research in Communities

Shawnell Damon

Dr. Mona AuYoung

Rev. Dr. Kendrick E. Curry

Venus Ginés

Dr. Raynald Samoa

Dr. Victor Sutton

Ready to take another step?

Ensure Safety

Dr. Evi Abada

Dr. Andrew Campbell

Laurie Carr

Dr. Lisa A. Cooper

Dr. Jaime G. Deville

Ysabel Duron

Dr. Jennifer Knight-Madden

Dr. Geeta Krishna Swamy

Dr. Hsin-Chieh "Jessica" Yeh

Ready to take another step?

Volunteer

Emelina Asto-Flores

Geraldine Bradshaw

Dr. Craig E. Cameron

Dr. Keisha L. Gibson

Marcia Jackson-Hooper

Julia Kachar

Mir Majeed

Dr. Richard Moye

Justice Zimmerman

Ready to take another step?

Provide Care

Dr. Hina Talib

Dr. Carolyn Allen

Monica Atkinson

Dr. Olveen Carrasquillo

Dr. Alejandra Casillas

Dr. Yelba M. Castellon-Lopez

Dr. Chyke A. Doubeni

Dr. Robert Gillespie

Dr. MeiLan Han

Dr. Paule V. Joseph

Dr. Yvonne (Bonnie) Maldonado

Tabe Mase

Dr. Ilan Shapiro Strygler

Dr. Cydney Teal

Dr. Felix M. Valbuena, Jr.

Dr. Nita Vangeepuram

Dr. Zanthia Wiley

Ready to take another step?

Follow CEAL on social media

Sign up for the CEAL Newsletter